gip and glp-1 gelatin The dual glucose-dependent insulinotropic polypeptide (GIP) glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology Microdosing GLP-1/GIP for Women |

Sources: Sonthalia et al., 2018 , Narrative review, 2025 Precautions before treatment Disclose your full medical history, medicines and supplements Get a personalised dose and route from a qualified doctor Avoid if pregnant or breastfeeding Flag any known allergies or sensitivities Self-medication or IV use without medical supervision can pose serious health risks

A review in Current Sports Medicine Reports warned of the widespread use of peptides from non-clinical suppliers, highlighting the lack of sterility and the high incidence of batch inconsistencies (1)

These findings suggest that GLP-1 RAs, commonly prescribed for type 2 diabetes and obesity, may positively influence bone healing and fusion durability, while also diminishing early postoperative complications such as sepsis and hospital readmission

P., Singh, L